Kanako Yasuda
About
In The Last Decade
Kanako Yasuda
70 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 66
- Ophthalmology 1.4k
- Radiology, Nuclear Medicine and Imaging 851
- Molecular Biology 200
- Plant Science 76
- Clinical Biochemistry 58
Countries citing papers authored by Kanako Yasuda
This map shows the geographic impact of Kanako Yasuda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kanako Yasuda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kanako Yasuda more than expected).
Fields of papers citing papers by Kanako Yasuda
This network shows the impact of papers produced by Kanako Yasuda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kanako Yasuda. The network helps show where Kanako Yasuda may publish in the future.
Co-authorship network of co-authors of Kanako Yasuda
This figure shows the co-authorship network connecting the top 25 collaborators of Kanako Yasuda. A scholar is included among the top collaborators of Kanako Yasuda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kanako Yasuda. Kanako Yasuda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 13 | |
| 3 | Dynamics of inflammatory factors in aqueous humor under Ranibizumab or Aflibercept treatment for age-related macular degeneration | 1 |
| 4 | 8 | |
| 5 | 17 | |
| 6 | 26 | |
| 7 | 12 | |
| 8 | Role of Soluble Vascular Endothelial Growth Factor Receptor Signaling and Other Factors or Cytokines in Diabetic Macular Edema | 1 |
| 9 | 14 | |
| 10 | 19 | |
| 11 | Dynamic change of aqueous concentrations of cytokines and their receptors during the clinical course of ranibizumab treatment in diabetic macular edema. | 1 |
| 12 | Dynamic change of aqueous concentrations of VEGF and its soluble receptors during the treatment of aflibercept in patients with age-related macular degeneration | 0 |
| 13 | 10 | |
| 14 | Comparison Of Blood Retinal Flow In Severe Diabetic Retinopathy Treated With Panretinal Photocoagulation Performed With A Pattern Scan Laser Versus A Conventional Laser | 1 |
| 15 | 11 | |
| 16 | 8 | |
| 17 | Diclofenac prevents temporal increase of intraocular pressure after uneventful cataract surgery with longer operation time | 2 |
| 18 | Comparative Therapy Evaluation of Intravitreal Bevacizumab and Triamcinolone Acetonide on Persistent Diffuse Diabetic Macular Edema | 29 |
| 19 | 24 | |
| 20 | 8 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.